100,000 Shares in SPDR S&P Biotech ETF $XBI Bought by Lalia Capital LLC

Lalia Capital LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 100,000 shares of the exchange traded fund’s stock, valued at approximately $12,193,000. SPDR S&P Biotech ETF accounts for about 9.5% of Lalia Capital LLC’s investment portfolio, making the stock its 4th biggest holding. Lalia Capital LLC owned 0.15% of SPDR S&P Biotech ETF as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. China Universal Asset Management Co. Ltd. boosted its position in SPDR S&P Biotech ETF by 868.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after acquiring an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at $417,000. Banque Pictet & Cie SA boosted its position in SPDR S&P Biotech ETF by 24.1% during the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after acquiring an additional 12,595 shares during the last quarter. Apella Capital LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at $490,000. Finally, PNC Financial Services Group Inc. boosted its position in SPDR S&P Biotech ETF by 60.9% during the third quarter. PNC Financial Services Group Inc. now owns 70,527 shares of the exchange traded fund’s stock valued at $7,067,000 after acquiring an additional 26,705 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 3.6%

Shares of XBI opened at $128.67 on Friday. The stock has a market capitalization of $8.21 billion, a P/E ratio of 11.47 and a beta of 0.85. The firm’s fifty day simple moving average is $131.90 and its two-hundred day simple moving average is $126.56. SPDR S&P Biotech ETF has a 12 month low of $80.90 and a 12 month high of $139.19.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.